APA (7th ed.) Citation

Sinn, B., Loibl, S., Hanusch, C. A., Zahm, D., Sinn, P., Untch, M., . . . Denkert, C. (2021). Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer. Clinical cancer research, 27(9), . https://doi.org/10.1158/1078-0432.CCR-20-3113

Chicago Style (17th ed.) Citation

Sinn, Bruno, et al. "Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but Not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer." Clinical Cancer Research 27, no. 9 (2021). https://doi.org/10.1158/1078-0432.CCR-20-3113.

MLA (9th ed.) Citation

Sinn, Bruno, et al. "Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but Not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer." Clinical Cancer Research, vol. 27, no. 9, 2021, https://doi.org/10.1158/1078-0432.CCR-20-3113.